市场调查报告书

血管移植的全球市场预测:各材料,产品(血液透析机通路,血管内支架,其他),用途,地区

Vascular Graft Market: By Raw Material (Polyester, Polytetrafluoroethylene, Others); By Product (Hemodialysis Access, Endovascular Stent, Others); By Application (Cardiovascular Diseases, Cardiac Aneurysm, Others) & By Region-Forecast 2019-2024

出版商 IndustryARC 商品编码 422788
出版日期 内容资讯 英文
商品交期: 2-3个工作天内
价格
血管移植的全球市场预测:各材料,产品(血液透析机通路,血管内支架,其他),用途,地区 Vascular Graft Market: By Raw Material (Polyester, Polytetrafluoroethylene, Others); By Product (Hemodialysis Access, Endovascular Stent, Others); By Application (Cardiovascular Diseases, Cardiac Aneurysm, Others) & By Region-Forecast 2019-2024
出版日期: 2018年12月22日内容资讯: 英文
简介

本报告提供血管移植的全球市场调查,各材料、产品、用途、地区的市场趋势及市场成长预测,推动、阻碍市场要素,市场机会,竞争分析,以及主要企业的简介等汇整。

第1章 血管移植的全球市场:市场概要

第2章 摘要整理

第3章 血管移植的全球市场:市场形势

  • 市场占有率分析
  • 比较分析
  • 产品基准
  • 终端用户简介
  • 前五名公司的财务分析

第4章 血管移植的全球市场:市场动态

  • 市场推动因素
  • 市场阻碍因素
  • 市场机会
  • 市场课题
  • 波特的五力分析

第5章 血管移植的全球市场:策略分析

  • 价值链分析
  • 价格分析
  • 市场机会分析
  • 产品/市场生命周期分析
  • 供给、流通

第6章 血管移植的全球市场:各材料

  • 聚酯
  • 聚四氯乙烯
  • 聚氨酯
  • 生物来源物质

第7章 血管移植的全球市场:各产品

  • 血液透析机通路移植
  • 血管内血管支架
  • 末稍血管
  • 冠状动脉绕道手术移植(CABG)

第8章 血管移植的全球市场:各用途

  • 心血管疾病
  • 心脏动脉瘤
  • 肝功能障碍
  • 血管闭塞

第9章 血管移植的全球市场:各地区

  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 英国
    • 其他各国
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他地区
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 其他地区
    • 巴西

第10章 血管移植的全球市场:熵

  • 市场扩大
  • 技术的发展
  • 合并、收购、合资企业
  • 供给契约

第11章 企业简介

第12章 附录

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录

Vascular graft procedures are minimally invasive besides involving repairing vessels from the inside as compared to other conventional vascular surgical procedure. In vascular graft procedures, Catheter-based devices are introduced through a minor incision and are directed with the aid of real-time imaging technologies. Globally, development of efficient and advanced novel products using tissue engineered, and biological materials, rise in the awareness among people regarding peripheral artery diseases and coronary diseases, increasing government initiatives across the globe, growing prevalence of cardiovascular diseases such as hypertension, coronary artery disease, and cardiac aneurysms, and increasing prevalence of diabetes around the world are the prime growth drivers of the vascular graft market. In addition, an increase in adoption of vascular graft in emerging economies such as China, India and others, will create new opportunities for the vascular graft market. However, higher cost of the research and development, and higher cost of vascular graft procedures are the key restraints for the vascular graft market.

Geographically, North America dominated the vascular graft market, due to high medical reimbursement facilities, and technological advancement. Asia Pacific is projected to have the fastest growth, owing to a rapidly increasing geriatric population, rise in consumer awareness, increasing healthcare expenditure, favourable government policies, modernization of healthcare infrastructure, and growing medical tourism industry in developing nations such as China, and India in this region. Among all the applications, cardiovascular diseases has the highest market share in the vascular graft market due to higher prevalence of hypertension, high blood sugar and other age-related risk factors.

This report identifies the vascular graft market size for the years 2014-2016, and forecast of the same till the year 2022. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the vascular graft market.

This report segments the vascular graft market on the basis of raw material, product, application, and regional market as follows:

Vascular Graft Market, By Raw Material: Polyester, Polytetrafluoroethylene, Polyurethane, and Biological Materials

Vascular Graft Market, By Product: Hemodialysis Access Graft, Endovascular Stent Graft, Peripheral vascular, and Coronary Artery By-pass Graft

The report has focused study on vascular graft market on the basis of application such as: Cardiovascular Diseases, Cardiac Aneurysm, Kidney Failure, and Vascular Occlusion

This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the vascular graft market. Some of the major companies' profiles in detail are as follows:

Medtronic Inc.

Bard Peripheral Vascular Inc.

Shanghai Suokang Medical Implants Co., Ltd

W.L. Gore & Associates

Junken Medical Co., Ltd.

Table of Contents

1. Vascular Graft Market - Overview

2. Executive Summary

3. Vascular Graft Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
  • 3.3. Product Benchmarking
  • 3.4. End User Profiling
  • 3.5. Top 5 Financials Analysis

4. Vascular Graft Market- Forces

  • 4.1. Drivers
    • 4.1.1. Development of efficient and advance novel products using tissue engineered, and biological materials
    • 4.1.2. Growing prevalence of cardiovascular diseases such as hypertension, coronary artery disease, and cardiac aneurysms
  • 4.2. Restraints
    • 4.2.1. Higher cost of research and development
  • 4.3. Opportunities
    • 4.3.1. Emerging economies
  • 4.4. Challenges
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of New Entrants
    • 4.5.4. Threat of Substitutes
    • 4.5.5. Degree of Competition

5. Vascular Graft Market- Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Opportunities Analysis
  • 5.4. Product/Market Life Cycle Analysis
  • 5.5. Suppliers and Distributors

6. Vascular Graft Market, By Raw Material

  • 6.1. Polyester
  • 6.2. Polytetrafluoroethylene
  • 6.3. Polyurethane
  • 6.4. Biological Materials

7. Vascular Graft Market, By Product

  • 7.1. Hemodialysis Access Graft
  • 7.2. Endovascular Stent Graft
  • 7.3. Peripheral Vascular
  • 7.4. Coronary Artery By-Pass Graft

8. Vascular Graft Market, By Application

  • 8.1. Cardiovascular Diseases
  • 8.2. Cardiac Aneurysm
  • 8.3. Kidney Failure
  • 8.4. Vascular Occlusion

9. Vascular Graft Market, By Geography

  • 9.1. Europe
    • 9.1.1. Germany
    • 9.1.2. France
    • 9.1.3. Italy
    • 9.1.4. Spain
    • 9.1.5. Russia
    • 9.1.6. U.K.
    • 9.1.7. Rest of Europe
  • 9.2. Asia Pacific
    • 9.2.1. China
    • 9.2.2. India
    • 9.2.3. Japan
    • 9.2.4. South Korea
    • 9.2.5. Rest of Asia-Pacific
  • 9.3. North America
    • 9.3.1. U.S.
    • 9.3.2. Canada
    • 9.3.3. Mexico
  • 9.4. Rest of the World (RoW)
    • 9.4.1. Brazil
    • 9.4.2. Rest of RoW

10. Vascular Graft - Entropy

  • 10.1. Expansion
  • 10.2. Technological Developments
  • 10.3. Merger & Acquisitions, and Joint Ventures
  • 10.4. Supply- Contract

11. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

  • 11.1. Medtronic Inc.
  • 11.2. Bard Peripheral Vascular Inc.
  • 11.3. Shanghai Suokang Medical Implants Co., Ltd
  • 11.4. W.L. Gore & Associates
  • 11.5. Junken Medical Co., Ltd.
  • 11.6. Getinge Group
  • 11.7. Cook Medical
  • 11.8. LeMaitre Vascular Inc.
  • 11.9. Humacyte, Inc.
  • 11.10. Terumo Medical Corporation

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

12. Appendix

  • 12.1. Abbreviations
  • 12.2. Sources
  • 12.3. Research Methodology
  • 12.4. Bibliography
  • 12.5. Compilation of Expert Insights
  • 12.6. Disclaimer